{"url_path":"/sec/prof/8-k/2026-05-15/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1628808/0001104659-26-062509-index.html","accession_number":"0001104659-26-062509","cik":"0001628808","ticker":"PROF","issuer_name":"Profound Medical Corp.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1628808/0001104659-26-062509-index.html","primary_entity_key":"0001628808","primary_entity_name":"Profound Medical Corp."},"word_count":366,"has_tables":true,"body_markdown":"**Item 5.07. Submission of Matters to a Vote\nof Security Holders**\n\n \n\nAt\nthe 2026 Annual General and Special Meeting of Shareholders of Profound Medical Corp. (the “Company”) held on May 13,\n2026, the holders of common shares of the Company voted on: (1) eight director nominees to be elected to the Board of Directors of the\nCompany (the “Board”) to serve until the close of the Company’s next annual meeting of shareholders or until their respective\nsuccessors have been appointed; (2) the appointment of PricewaterhouseCoopers LLP as auditors of the Company until the close of the\nCompany’s next annual meeting of shareholders at such remuneration to be fixed by the Board; and (3) an ordinary resolution\napproving all unallocated restricted share units and deferred share units under the Company’s long-term incentive plan. The items\nof business are further described in the Company’s management information circular filed as Exhibit 99.1 to this Current Report\non Form 8-K.\n\n \n\nThe tables below set forth\nthe number of votes cast for, against or withheld, for each matter voted on by the Company’s shareholders.\n\n \n\n1.Election of Directors\n\n \n\nEach of the eight nominees listed below was elected\nas director of the Company to hold office until the Company’s next annual meeting of shareholders or until their successor is duly\nappointed.\n\n \n\n**Nominee**\n**For**\n**% For**\n**Withheld**\n**% Withheld**\n\nArun Menawat\n12,773,374\n90.257\n1,378,792\n9.743\n\nBrian Ellacott\n11,541,684\n81.554\n2,610,482\n18.446\n\nCynthia Lavoie\n11,586,793\n81.873\n2,565,373\n18.127\n\nMurielle Lortie\n11,586,693\n81.872\n2,565,473\n18.128\n\nArthur Rosenthal\n11,180,113\n78.999\n2,972,053\n21.001\n\nFrank Baylis\n12,945,473\n91.473\n1,206,693\n8.527\n\nThomas Wellner\n12,948,509\n91.495\n1,203,657\n8.505\n\nVafa Jamali\n12,885,003\n91.046\n1,267,163\n8.954\n\n \n\n2.Appointment of Auditors\n\n \n\nThe shareholders approved the appointment of PricewaterhouseCoopers\nLLP as auditors of the Company until the close of the Company’s next annual meeting of shareholders at such remuneration to be fixed\nby the Board.\n\n \n\n**Votes For**\n**% For**\n**Votes Withheld**\n**% Withheld**\n\n25,193,910\n99.497\n127,301\n0.503\n\n \n\n3.Approval of Unallocated Restricted Share Units and Deferred Share Units under the Long-Term Incentive Plan\n\n \n\nThe shareholders approved\nan ordinary resolution approving all unallocated restricted share units and deferred share units under the Company’s long-term incentive\nplan.\n\n \n\n**Votes For**\n**% For**\n**Votes Against**\n**% Against**\n\n9,046,376\n63.922\n5,105,787\n36.078"}